We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01148212
First Posted: June 22, 2010
Last Update Posted: February 8, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
Ludwig-Maximilians - University of Munich
June 21, 2010
June 22, 2010
February 8, 2011
June 2009
December 2010   (Final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT01148212 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)
Safety and Tolerability of Transcranial Direct Current Stimulation (tDCS)

Testing safety and tolerability of transcranial direct current stimulation (2 mA, 20 minutes) in four different protocols:

saline-soaked sponges electrode with electrode gel tap-water-soaked sponges tap-water-soaked-sponges + sham stimulation

Outcome measures are tolerability (comfort rating questionnaire), impedances, skin elasticity

Not Provided
Observational
Observational Model: Case-Only
Not Provided
Not Provided
Probability Sample
15 healthy volunteers
Best Comfort and Lowest Skin Irritation
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
15
January 2011
December 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • no neurological or psychiatric illness
  • written informed consent

Exclusion Criteria:

  • dermatologic diseases
  • medication with corticoids
Sexes Eligible for Study: All
18 Years to 65 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Germany
 
 
NCT01148212
10/2009
No
Not Provided
Not Provided
Ulrich Palm, MD, Ludwig-Maximilian-University Munich
Ludwig-Maximilians - University of Munich
Not Provided
Principal Investigator: Ulrich Palm, MD Ludwig-Maximilian-University
Study Chair: Frank Padberg, MD Ludwig-Maximilian-University
Ludwig-Maximilians - University of Munich
January 2011